Potent Narcotic ‘Lollipop’ Becomes Best Seller_WSJ
Off-label prescribing of drugs for unapproved uses puts consumers at high risk of harm–but it is the single most lucrative marketing strategy.
Off-label prescribing of drugs for unapproved uses puts consumers at high risk of harm–but it is the single most lucrative marketing strategy.
Two surveys confirm medical researchers' resistance to complying with conflict of interest disclosure requirements.
Business Week reports: "From 1986 to 2003 the number of nonsurgical cardiac procedures, such as propping open arteries with wire-mesh stents, rose twelve fold, according to the American Heart Association.
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 10a, 2002 U.S. Bio-Tech Start-ups Conducting CheapPreliminary Studies in China FYI Harvard University is not the only one exploiting China’spoor population for medical experiments. Violations of…
Artificial Heart Implant Leads to Suit Over Consent Process Recipient’s Widow Says She and Her Husband Were Misinformed and Misled on Risks, Benefits By Debbie Goldberg Special to The Washington Post Saturday, November 30, 2002; Page A03 http://www.washingtonpost.com/ac2/wp-dyn/A54921-2002Nov29?language=printerwashingtonpost.com PHILADELPHIA, Nov. 25 — When James Quinn, a 51-year-old Vietnam veteran dying…
Junk Science Hits Front Page Headlines: Most Americans Will Be Mentally Ill at Some Point – NIMH / Harvard Study Says Tue, 7 Jun 2005 Americans may be astonished to learn that $20 million in taxpayers’ money was spent on a study whose unacknowledged purpose is to increase the use…
Ethics of U Penn surgical “drug implant” experiment Tuesday, October 07 Notwithstanding a legion of prominent bioethicists at major universities such as the University of Pennsylvania and Johns Hopkins University, researchers at these institutions are not deterred from engaging in high risk human experimentation whose ethics are questionable. One has…
AHRP Opposes Drug Implants for Psychiatric Patients Those promoting the implants focus on its delivery of continuous sustained drug action to ensure that patients take the drugs they’re prescribed, presumably to prevent relapse. But critics who are familiar with widespread psychotropic drug prescribing abuses recognize the serious potential for harm…
Charitable Choice: Research Grants–Juvenile Diabetes Research Foundation – National Journal Tue, 8 Mar 2005 The Washington Post reports that conservatives have crafted a “bioethics agenda” on cloning and stem cell research. Such an agendaq determines what research the government will and will not fund. http://www.washingtonpost.com/wp-dyn/articles/A15569-2005Mar7.html Below is an excerpt of…
Artificial Heart experiment without informed consent? Wed, 30 Apr 2003 The manufacturer of an artificial heart, Abiomed, are seeking to use incapacitated patients who suffered a massive heart attack as human subjects without their informed consent. Does anyone have the moral or legal right to subject a human being to…
Commentary by Vera Hassner Sharav February 18, 2002Â FYI United States Government Sponsored Genetic Research in Rural China Raises Troubling Ethical Concerns A January 2002 report in China Daily, byXiong Lei, the senior journalist with China Features, Xinhua News Agency(below), raises troubling ethical concerns about U.S. government-sponsoredgenetic research in rural…
Lies & Broken Promises_Drug firm Websites Fail to Disclose Test Data Sun, 9 Jan 2005 One year after PhRMA’s publicized proclamation of its “commitment to transparency” The Boston Globe reviewed pharmaceutical company websites searching for disclosure of clinical trial data. The Globe found that this voluntary approach failed miserably: “Last…